Antares Pharma reported $6.79M in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US $ 2522M 1123M
Adamas Pharmaceuticals ADMS:US -5636000 3.52M
Adma Biologics ADMA:US $ -14437080 1.14M
Aerie Pharmaceuticals AERI:US $ -32374000 873K
Ani Pharmaceuticals ANIP:US $ -3335000 3.3M
Atrion ATRI:US 9.48M 317K
Becton, Dickinson and BDX:US $ 776M 250M
Cerus CERS:US $ -11126000 3.28M
Eli Lilly And LLY:US $ 2055.2M 626.8M
Endo International Ordinary Shares ENDP:US $ 207.28M 11.74M
Horizon Pharma HZNP:US 345.45M 131.68M
JAZZ PHA JAZZ:US 28.37M 97.96M
Meridian Bioscience VIVO:US $ 13.75M 2.67M
Orasure Technologies OSUR:US $ -13513000 15.09M
Pacira Pharmaceuticals PCRX:US $ 30.72M 4.27M
Pfizer PFE:US $ 9254M 2592M
Revance Therapeutics RVNC:US $ -72723000 2.39M
Rockwell Medical RMTI:US -6972000 851K
Sientra SIEN:US $ -11694000 2.54M
Staar Surgical STAA:US $ 7.84M 2.81M
Supernus Pharmaceuticals SUPN:US $ 32.6M 1.51M
Teva Pharmaceutical TEVA:IT 806M 23M
Teva Pharmaceutical Industries TEVA:US 806M 23M
Zogenix ZGNX:US $ -53870000 1.56M